Opdivo And Cometriq Drugs Proven More Effective Than Novartis' Afinitor As Advanced Kidney Cancer Treatment

Cometriq and Opdivo could likely receive approval next year as treatment for advanced kidney cancer after studies showed positive result. One study was halted earlier than schedule because patients taking Opdivo lived longer than those receiving standard treatment.